廣信材料(300537.SZ)擬投資設立全資子公司湖南廣裕
格隆匯6月18日丨廣信材料(300537.SZ)公佈,公司擬在湖南省長沙市出資人民幣1000萬元設立湖南廣裕感光新材料有限公司(暫定名稱,該子公司名稱最終以市場監督管理部門核准結果為準,以下簡稱“湖南廣裕”),進行塗料製造、油墨及類似產品、電子專用材料、其他合成材料的研發、製造、銷售及技術服務。
本次投資設立的全資子公司未來可能在經營過程中面臨市場、經營、管理等各方面不確定因素帶來的風險,公司將採取適當的策略、管理措施加強風險管控,以不斷適應業務要求及市場變化,積極防範和應對上述風險,力爭為股東帶來良好的投資回報。敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.